Quantcast

Horizon In-licenses Oncology Programme from Servier and Enters Option Agreement

Horizon Discovery Group plc, the international life science company supplying research tools and services that power genomics research and the development of personalised medicines, has announced that its leveraged business unit has signed a programme in-licensing and option agreement with Servier, the independent French research-based pharmaceutical company .

Read more